BioWorld

Dec. 13, 2010

The Game of Risk: Mitigation, Funding, World Domination

The object of the military-themed board game might be total world domination, but in the biotech game of risk, just surviving can be tricky enough. Read More

Money Raised Year to Date

MMRC ASH Data Validate Better-Faster-Cheaper Trials

Cancer Drug Causes Cancer: Catastrophe or Minor Blip?

Money Raised By Biotech in 2010

Week in Review

Word on the Street

Week in Washington

Phase I Clinical Trials Update: November 2010

Phase II Clinical Trials Update: November 2010

Phase III Clinical Trials Update: November 2010

American Association for the Study of Liver Diseases

American College of Rheumatology

American Heart Association

European Organisation for Research and Treatment of Cancer

Non-U.S. Clinical Trials & Regulatory Actions: Nov. 2010

FDA Submissions, Approvals & Other Actions: Nov. 2010

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for June 3, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...